TheEdgeResearch
Home / Stocks / GCTK

GlucoTrack, Inc. (GCTK)

NASDAQ Healthcare Medical - Devices
$0.45 ▲ +2.27%
Market Cap
$179,582
Sector
Healthcare
Industry
Medical - Devices
Beta
0.72
52-Wk Range
0.342-207
CEO
Erik Emerson
Country
US
Currency
USD

GlucoTrack, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Rutherford, NJ, US. The stock last traded at $0.45, up 2.27% on the session, giving a market capitalisation of $179,582. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 0.72 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.03
EV / EBITDA
0.06
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.01
Current ratio
0.46
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
15
IPO date
2013-04-25
Headquarters
Rutherford, NJ, US
About GlucoTrack, Inc.

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Comparable companies

GlucoTrack, Inc. is most often compared with the following Healthcare names:

AKANBBLGBGMSDHAIHSCSINMNAOVNDRARDHLVERO
More research on GCTK
GCTK technical analysis GCTK TheEdge Score Compare against peers
Open full interactive analysis & DCF →